When your child is diagnosed with cancer, everything changes. Families face long hospital stays, tough treatments and overwhelming emotions. That’s where supportive care comes in and thanks to Rally Foundation for Childhood Cancer Research, one doctor’s vision is now helping kids and families across the country.  Katharine Brock, a palliative care doctor at Children’s Healthcare of Atlanta and researcher at Emory University, received early research funding from Rally Foundation from 2016-2019...

Did you know that some medicines are so smart they can go right to the bad stuff and leave the good stuff alone? That’s exactly what Xiaoyang Wu, Ph.D., at the University of Chicago has been working on, and it could help kids with cancer feel better, faster.  Dr. Wu got early research funding from the Rally Foundation in 2024. That grant helped him and his team test something amazing in the lab: super-tiny particles called nanoparticles that can carry cancer-fighting medicine straight to the...

Brain cancer is scary, especially when it affects kids. A group of brain cancers, called pediatric high-grade gliomas, are both common and hard to treat. But thanks to funding from Rally Foundation for Childhood Cancer Research, Renee Read, Ph.D., a scientist at Emory University, is doing something about it.  Dr. Read’s research focuses on finding weak spots in these tough brain tumors, kind of like finding a secret button that makes the bad guys disappear.  What She Discovered  Dr. Read and...

Dr. David Loeb, M.D., Ph.D., from the Montefiore Einstein Comprehensive Cancer Center, has dedicated his career to finding better treatments for children with sarcoma, a type of childhood cancer. Early support from Rally Foundation helped him take the first big steps in his research journey. In 2012, Dr. Loeb received his first Rally grant. This funding helped him study how Ewing sarcoma cancer cells use energy differently than healthy cells. Those first experiments led to important...

When Eric Rellinger, M.D., was training to become a surgeon at Vanderbilt University Medical Center, he became fascinated by how cancer cells survive. He realized that cancers keep growing because they constantly demand more building blocks inside the body, helping them resist treatments that are meant to stop them. His first research project studied special enzymes called NADPH oxidases in neuroblastoma, a very aggressive type of childhood cancer. These enzymes help produce molecules that...

When we first met Kevin Bunting, Ph.D., from Emory University, we saw a scientist with big ideas and bold goals. His work focused on finding new ways to fight acute myeloid leukemia (AML), one of the most aggressive forms of childhood cancer. Rally Foundation for Childhood Cancer Research was the first organization to believe in his vision, providing seed funding for two early projects. That early support helped Dr. Bunting and his team focus on a protein called STAT5. When STAT5 is activated,...